Pharmacist Intervention to Improve Smoking Cessation
A Remote Pharmacist Intervention to Improve Smoking Cessation
Sponsor: University of Iowa
This observational or N/A phase trial investigates Smoking Cessation and is currently ongoing. University of Iowa leads this study, which shows 5 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Apr 18, 2026 — Present [daily]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting · Phase: NA → None
-
Feb 2026 — Apr 2026 [monthly]
Enrolling By Invitation NA
-
Sep 2025 — Feb 2026 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Jun 2025 — Sep 2025 [monthly]
Not Yet Recruiting NA
-
May 2025 — Jun 2025 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
The goal of this study is to assess the effectiveness of a remote pharmacist intervention to help smokers quit. The main questions it aims to answer are: * Will smokers being screened for lung cancer with low-radiation-level chest computed tomography (CT) be willing to participate in this study and talk to the pharmacist about smoking cessation? * Will those in the intervention group be more likely to report smoking cessation than those in the control group. Participants in the intervention group will be asked to complete a baseline survey; speak with a pharmacist via phone call at baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks, and 12 weeks; and complete an exit survey. Participants in the control group will be asked to complete a baseline survey and an exit survey.
Contact Information
- University of Iowa
For direct contact, visit the study record on ClinicalTrials.gov .